These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35410713)
1. Novel approaches to the surveillance and management of fetuses at risk for anti-Ro/SSA mediated atrioventricular block. Kaplinski M; Cuneo BF Semin Perinatol; 2022 Jun; 46(4):151585. PubMed ID: 35410713 [TBL] [Abstract][Full Text] [Related]
3. Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro/SSA-antibody-positive pregnancies. Cuneo BF; Bitant S; Strasburger JF; Kaizer AM; Wakai RT Ultrasound Obstet Gynecol; 2019 Nov; 54(5):625-633. PubMed ID: 30784137 [TBL] [Abstract][Full Text] [Related]
4. Home fetal heart rate monitoring in anti Ro/SSA positive pregnancies: Literature review and case report. Milazzo R; Ligato E; Laoreti A; Ferri G; Basili L; Serati L; Brucato A; Cetin I Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():1-6. PubMed ID: 33556767 [TBL] [Abstract][Full Text] [Related]
5. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471 [TBL] [Abstract][Full Text] [Related]
6. Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers. Kaizer AM; Lindblade C; Clancy R; Tebo AE; Drewes B; Masson M; Chang M; Fraser N; Buyon JP; Cuneo BF Am J Obstet Gynecol; 2022 Nov; 227(5):761.e1-761.e10. PubMed ID: 35690080 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center. Krishnan A; Arya B; Moak JP; Donofrio MT Prenat Diagn; 2014 Dec; 34(12):1207-12. PubMed ID: 24989941 [TBL] [Abstract][Full Text] [Related]
8. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies. Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562 [TBL] [Abstract][Full Text] [Related]
9. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309 [TBL] [Abstract][Full Text] [Related]
10. Atrioventricular conduction delay in the second trimester measured by fetal magnetocardiography. Wacker-Gussmann A; Paulsen H; Stingl K; Braendle J; Goelz R; Henes J J Immunol Res; 2014; 2014():753953. PubMed ID: 24741622 [TBL] [Abstract][Full Text] [Related]
11. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block. Mevorach D; Elchalal U; Rein AJ Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727 [TBL] [Abstract][Full Text] [Related]
12. Heart sounds at home: feasibility of an ambulatory fetal heart rhythm surveillance program for anti-SSA-positive pregnancies. Cuneo BF; Moon-Grady AJ; Sonesson SE; Levasseur S; Hornberger L; Donofrio MT; Krishnan A; Szwast A; Howley L; Benson DW; Jaeggi E J Perinatol; 2017 Mar; 37(3):226-230. PubMed ID: 27977016 [TBL] [Abstract][Full Text] [Related]
13. Treatment and follow-up of fetuses that developed congenital heart block due to autoantibody in two cases. Hou M; Zhao Y; Liu XW; He YH J Int Med Res; 2020 Jun; 48(6):300060520925596. PubMed ID: 32588691 [TBL] [Abstract][Full Text] [Related]
14. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies. Sonesson SE; Ambrosi A; Wahren-Herlenius M Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419 [TBL] [Abstract][Full Text] [Related]
15. Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance. Bergman G; Eliasson H; Bremme K; Wahren-Herlenius M; Sonesson SE Ultrasound Obstet Gynecol; 2009 Nov; 34(5):543-9. PubMed ID: 19795521 [TBL] [Abstract][Full Text] [Related]
16. Complete atrioventricular block in adult Sjögren's syndrome with anti-Ro autoantibody. Sung MJ; Park SH; Kim SK; Lee YS; Park CY; Choe JY Korean J Intern Med; 2011 Jun; 26(2):213-5. PubMed ID: 21716914 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro/SSA antibody-mediated cardiac disease. Cuneo BF; Fruitman D; Benson DW; Ngan BY; Liske MR; Wahren-Herlineus M; Ho SY; Jaeggi E Am J Cardiol; 2011 Mar; 107(5):761-6. PubMed ID: 21247531 [TBL] [Abstract][Full Text] [Related]
19. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block. Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741 [TBL] [Abstract][Full Text] [Related]